End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.05 CNY | -0.29% | +19.56% | -5.85% |
Chart calendar Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Upcoming events on Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Past events on Dizal (Jiangsu) Pharmaceutical Co., Ltd.
30/04/2024 | Q4 2023 Earnings Release |
29/04/2024 | Q1 2024 Earnings Release |
28/10/2023 | Q3 2023 Earnings Release |
30/08/2023 | Q2 2023 Earnings Release |
06/06/2023 08:15 pm | American Society of Clinical Oncology Conference - Abstract #7503 |
06/06/2023 08:15 pm | American Society of Clinical Oncology Conference - Abstract #9002 |
04/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Abstract #9103 |
04/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Abstract #9073 |
29/04/2023 | Q1 2023 Earnings Release |
24/03/2023 | Q4 2022 Earnings Release |
29/10/2022 | Q3 2022 Earnings Release |
05/09/2022 | European Society for Medical Oncology Meeting |
26/08/2022 | Interim 2022 Earnings Release |
12/06/2022 03:00 pm | European Hematology Association Meeting - Abstract #S218 |
06/06/2022 11:30 pm | American Society of Clinical Oncology Meeting - Abstract #9015 |
06/06/2022 06:30 pm | American Society of Clinical Oncology Meeting - Abstract #9015 |
06/06/2022 06:30 pm | American Society of Clinical Oncology Meeting - Abstract #1038 |
04/06/2022 06:30 pm | American Society of Clinical Oncology Meeting - Abstract #7563 |
03/06/2022 | American Society of Clinical Oncology Meeting - Abstract #e15106 |
28/04/2022 | Q1 2022 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 0,00 | 10,3 11,0 -6.5% | 0,00 0,00 - | 91,3 108 -15.47% |
EBITDA Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | -692 -690 -0.35% | -1 060 -884 -19.93% |
EBIT Million CNY | Released Forecast Spread | 0,00 | -670 -637 -5.16% | -736 -722 -1.9% | -1 108 -989 -11.96% |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -670 -637 -5.16% | -736 -722 -1.87% | -1 108 -989 -11.96% |
Net income Million CNY | Released Forecast Spread | -587 | -670 -637 -5.16% | -736 -722 -1.91% | -1 108 -990 -11.93% |
EPS CNY | Released Forecast Spread | -1,63 | -1,86 -1,59 -16.98% | -1,82 -1,78 -2.25% | -2,72 -2,42 -12.24% |
Announcement Date | 22/11/21 | 25/02/22 | 27/02/23 | 24/02/24 |
Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
06/05/2024 | BIONTECH SE: Q1 2024 Earnings Release |
06/05/2024 04:30 pm | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
07/05/2024 01:31 am | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
07/05/2024 | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688192 Stock
- Calendar Dizal (Jiangsu) Pharmaceutical Co., Ltd.